Takeda Pharmaceutical is Japan’s largest pharmaceutical company, global after the Shire acquisition, in GI, oncology and rare disease. It trades on the Tokyo Stock Exchange under code 4502, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | 4502 |
| Exchange | Tokyo Stock Exchange (TYO: 4502) |
| Sector | Pharmaceuticals |
| Headquarters | Osaka / Tokyo, Japan |
Bull Case & Risks
Bull Case
- A global, diversified drug portfolio
- Rare-disease and GI franchises
- A high dividend yield
Risks
- Post-Shire debt and patent cliffs
- Pipeline-replacement risk
Outlook
Takeda is Japan’s largest, now-global drugmaker; the story is balancing patent cliffs and debt against its pipeline.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.